Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Ther Drug Monit. 2021 Dec 1;43(6):756–765. doi: 10.1097/FTD.0000000000000878

Table 2.

Intra- and inter-day coefficients of variation and recovery for the six drugs in hair.

Compound Nominal a (pg/mg) Intra-day CV (n=5, %) b Inter-day CV (n=5, %) b Recovery (M±SD, %) c
Lamivudine 6 3.1 6.3
10 4.3 7.6 112.5±4.8
2000 3.0 5.4 94.4±2.8
4000 3.2 4.3 104.2±3.3
Zidovudine 10 12.4 12.0
20 6.0 7.4 98.0±5.9
2000 3.5 6.2 96.7±3.4
4000 3.9 5.2 108.8±4.2
Nevirapine 6 6.3 5.7
10 3.8 8.0 107.6±4.1
20000 4.3 4.8 93.1±4.0
40000 9.2 7.5 95.6±8.8
Efavirenz 12 6.9 8.0
20 4.7 7.3 98.8±4.6
20000 7.8 6.7 91.1±7.1
40000 4.3 6.3 95.7±4.1
Ritonavir 8 9.1 9.2
20 3.1 5.1 105.4±3.2
2000 3.6 4.1 112.0±4.0
4000 2.6 3.0 112.1±2.9
Lopinavir 8 7.5 7.5
20 3.8 4.2 95.2±3.6
4000 2.4 3.3 113.7±2.7
10000 2.3 4.1 110.7±2.5
a

Intra- and inter-day coefficients of variation (CVs) were calculated at four levels, limits of quantitation (LOQ), low, medium, and high concentrations.

b

Intra-day and inter-day precisions were estimated by CVs.

c

Recovery was evaluated at three levels, low, medium, and high concentrations.